11,301 Shares of Colgate-Palmolive Company $CL Purchased by NBT Bank N.A.

NBT Bank N.A. purchased a new position in shares of Colgate-Palmolive Company (NYSE:CL) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund purchased 11,301 shares of the company’s stock, valued at approximately $964,000.

A number of other institutional investors and hedge funds have also modified their holdings of the business. State Street Corp lifted its holdings in Colgate-Palmolive by 97.4% in the second quarter. State Street Corp now owns 94,195,992 shares of the company’s stock valued at $8,635,889,000 after buying an additional 46,476,510 shares during the period. Bank of New York Mellon Corp grew its holdings in Colgate-Palmolive by 8.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 13,532,417 shares of the company’s stock worth $1,240,652,000 after acquiring an additional 1,010,872 shares during the period. First Eagle Investment Management LLC raised its position in shares of Colgate-Palmolive by 1.1% during the 2nd quarter. First Eagle Investment Management LLC now owns 8,205,699 shares of the company’s stock valued at $752,298,000 after acquiring an additional 88,917 shares during the last quarter. Bank of America Corp DE raised its position in shares of Colgate-Palmolive by 17.4% during the 1st quarter. Bank of America Corp DE now owns 6,637,597 shares of the company’s stock valued at $565,722,000 after acquiring an additional 986,063 shares during the last quarter. Finally, Amundi lifted its stake in shares of Colgate-Palmolive by 19.9% in the 2nd quarter. Amundi now owns 6,218,257 shares of the company’s stock valued at $570,090,000 after purchasing an additional 1,033,918 shares during the period. 80.41% of the stock is owned by institutional investors.

More Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Analysts expect earnings growth, and Zacks says Colgate-Palmolive has a favorable combination of earnings estimates and historical earnings surprises that could support a quarterly beat. Colgate-Palmolive earnings expectations
• Positive Sentiment: Recent coverage has highlighted strong toothpaste performance, while Colgate-Palmolive India reported 12.2% revenue growth, 4.3% profit growth and modest gross-margin expansion. These results may offer some support for the broader brand portfolio, although the Indian subsidiary is not the same entity as the U.S.-listed parent. Colgate-Palmolive India quarterly results
• Neutral Sentiment: Options activity was elevated, with investors purchasing 4,443 put contracts—about 71% above typical volume—signaling increased hedging or bearish positioning ahead of the report, but not necessarily confirming a change in fundamentals.
• Neutral Sentiment: Institutional positioning was mixed in the latest quarter: 851 investors added shares while 853 reduced holdings. Analyst targets remain varied, with a reported median of $96, suggesting limited upside relative to recent trading levels.
• Negative Sentiment: Investors remain concerned about raw-material and packaging inflation, tariff effects, intense category competition and pressure on consumer spending. Management has also warned that volatile market conditions could persist through the rest of 2026. Colgate-Palmolive defensive rally and earnings risks
• Negative Sentiment: Insiders have reported five open-market sales and no purchases over the past six months, including substantial sales by CEO Noel Wallace. While insider transactions can reflect personal financial decisions, the lack of buying may weigh on sentiment.

Insider Buying and Selling at Colgate-Palmolive

In related news, CEO Noel R. Wallace sold 161,021 shares of the firm’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the sale, the chief executive officer directly owned 362,231 shares in the company, valued at $33,296,273.52. This trade represents a 30.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Panagiotis Tsourapas sold 10,000 shares of the firm’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $92.05, for a total transaction of $920,500.00. Following the sale, the chief operating officer owned 64,901 shares in the company, valued at approximately $5,974,137.05. The trade was a 13.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 175,191 shares of company stock valued at $16,110,903. 0.43% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on CL. Jefferies Financial Group restated a “hold” rating and issued a $89.00 price target (up from $88.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Royal Bank Of Canada reiterated an “outperform” rating and issued a $104.00 price objective on shares of Colgate-Palmolive in a report on Tuesday, September 8th. JPMorgan Chase & Co. increased their target price on Colgate-Palmolive from $103.00 to $104.00 and gave the company an “overweight” rating in a research note on Monday, October 19th. Weiss Ratings lowered Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 2nd. Finally, Sanford C. Bernstein restated a “market perform” rating on shares of Colgate-Palmolive in a report on Thursday, August 13th. Thirteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $98.00.

Colgate-Palmolive Trading Down 3.4%

NYSE CL opened at $94.10 on Friday. The firm has a market cap of $75.02 billion, a P/E ratio of 37.34, a P/E/G ratio of 4.71 and a beta of 0.33. The company has a debt-to-equity ratio of 13.82, a current ratio of 1.03 and a quick ratio of 0.67. The stock’s 50-day moving average is $89.26 and its 200-day moving average is $89.35. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%. The business had revenue of $5.36 billion during the quarter, compared to analyst estimates of $5.36 billion. During the same period in the previous year, the firm earned $0.92 EPS. Colgate-Palmolive’s quarterly revenue was up 4.9% compared to the same quarter last year. Sell-side analysts anticipate that Colgate-Palmolive Company will post 3.87 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be paid a $0.53 dividend. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive’s payout ratio is presently 84.13%.

Colgate-Palmolive Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.